CARCINOMA IN SITU
Clinical trials for CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine-like therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study tests whether adding an experimental treatment (V940) to standard BCG therapy helps people with high-risk non-muscle invasive bladder cancer live longer without their cancer returning. About 308 adults will be randomly assigned to get either V940 plus BCG or BCG alone.…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New Tumor-Injected drug shows promise in early cancer trial
Disease control Recruiting nowThis early-stage trial tests a new drug called ONM-501, which is injected directly into tumors, either alone or with the immunotherapy cemiplimab (Libtayo). The study includes 168 adults with advanced solid tumors or lymphomas that have not responded to standard treatments. The m…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Massive childhood cancer registry launches to unlock better treatments
Knowledge-focused Recruiting nowThis study is a large registry that collects health information and leftover tumor or blood samples from up to 75,000 children and young adults with cancer. The goal is to track outcomes and gather data to help doctors find better ways to treat and care for these patients over ti…
Matched conditions: CARCINOMA IN SITU
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC